Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies of the drugmaker’s new Wegovy obesity pill and injections in the U.S.
CNBC’s Brandon Gomez has the details.
Enter your account data and we will send you a link to reset your password.
Here you'll find all collections you've created before.